Free shipping and returns

 

2023-03-17 Money Today
Original News

EX Healthcare (CEO Lee Yong-hee) announced on the 17th that it has recently signed MOUs (Memorandums of Understanding) with U.S. companies and universities, marking a significant step in its efforts to enter the American market. The company has also secured investment from In and Out Corporation, further accelerating its expansion plans in the U.S.

EX Healthcare specializes in researching exosomes secreted from the skin and has developed the world's first topical healthcare solution. Recently, the company signed an MOU with Dalton Bioanalytics, a U.S.-based company specializing in blood analysis technology, to jointly develop new therapeutic solutions leveraging exosome technology.

Through this partnership, the two companies aim to combine EX Healthcare's expertise in exosome control technology with Dalton Bioanalytics' blood analysis capabilities to create innovative solutions utilizing exosomes.

A representative from EX Healthcare stated, "This MOU will lay the groundwork for conducting global clinical trials for our products. Additionally, since Dalton Bioanalytics is based at UCLA, this collaboration will help establish our credibility on an international scale."

EX Healthcare has also partnered with California University of Management and Sciences (CALUMS), a California-based institution, on a joint research project aimed at developing innovative medical solutions using exosome control technology.

Under the agreement, CALUMS will contribute expertise in data analysis and biomarker discovery, while EX Healthcare will provide its knowledge of exosome control technology.

A company representative commented, "This industry-academic collaboration marks the starting point for establishing ourselves as a company that contributes to American society. We expect this partnership to broaden our research horizons and develop new technologies to address unmet medical needs."

Meanwhile, EX Healthcare was recently recognized as an outstanding company in the Initial Startup Package Program hosted by In and Out Corporation (N15), where it successfully secured investment. The funds raised will be allocated to overseas marketing, recruitment, and research and development (R&D) initiatives.

CEO Lee Yong-hee noted, "It is exceptional for a company to be selected for the Initial Startup Package Program just three months after its establishment. Competing against other highly accomplished startups, we ultimately succeeded in securing direct investment."

Ready for a Smarter Body Care Ritual?

Discover the first exosome-powered body cream that works beneath the surface — to protect what truly matters: your strength.

Try the Ritual

Latest Stories

View all

Are You Experiencing Muscle Burnout? 3 Signs You Shouldn’t Ignore

Are You Experiencing Muscle Burnout? 3 Signs You Shouldn’t Ignore

Muscle burnout isn’t just “being sore after a workout.” It’s your body signaling that it needs recovery, not more pressure. For young professionals and athletes in their 20s and 30s, the hustle culture often pushes us to train harder, but...

Read more

Shower. Cream. Breathe. Repeat: My 3-Second Morning and Night Muscle Ritual

Shower. Cream. Breathe. Repeat: My 3-Second Morning and Night Muscle Ritual

The Self-Care Hack Gen-Z Actually Has Time For Life moves fast, and let’s be real—most of us don’t have an hour to stretch, meditate, and roll out sore muscles twice a day. That’s why I created my 3-second morning and...

Read more

Skincare Went Scientific — Now It’s Bodycare’s Turn

Skincare Went Scientific — Now It’s Bodycare’s Turn

From face serums to full-body science, dermaFIT is changing the game. Why Should Your Face Get All the Science? For years, the skincare world has embraced cutting-edge science—think retinol, hyaluronic acid, peptides, and now exosomes—to reverse aging, boost cell communication,...

Read more